Sector Image

Building tomorrow’s great companies

Portfolio A to Z

Advent invests in two principal areas: Life Sciences and Technology. Its portfolio companies are in a variety of geographies, in a range of sectors and at differing stages of growth.

Next Page   1   2   3
Next Page   1   2   3
4-Antibody Novel technology for developing new antibodies
Advent Contact: Raj Parekh
4-Antibody
Adeptra Interactive alert services
Advent Contact: Martin McNair
Adeptra
Algeta Novel anticancer agents based on alpha emitters Oslo Bors IPO March 2007 (ALGETA)
Advent Contact: Shahzad Malik
Algeta
AmberFin Processing of digital media content
Advent Contact: Peter Baines
AmberFin
AMT Gene therapy for orphan indications Euronext IPO June 2007 (AMT)
Advent Contact: Raj Parekh
AMT
ASK Contactless smartcard design & manufacture
Advent Contact: Peter Baines
ASK
Audium Semiconductor Ultra energy-efficient audio semiconductors
Advent Contact: Martin McNair
Audium Semiconductor
Avila Development of novel small molecule drugs focused on cancer, autoimmune diseases and viral infection.
Advent Contact: Raj Parekh
Avila
BridgeCo Semi-conductors for networked consumer electronics
Advent Contact: Martin McNair
BridgeCo
Cardiac Assist Extracorporeal ventricular assist device
Advent Contact: Shahzad Malik
Cardiac Assist
CardioKine Cardio-renal drug development
Advent Contact: Shahzad Malik
CardioKine
Cellnovo Development of next-generation small disposable insulin pumps
Advent Contact: Raj Parekh
Cellnovo
Conatus Pharmaceuticals New therapeutic agents for treatment of liver disease.
Advent Contact: Shahzad Malik
Conatus Pharmaceuticals
Dailymotion Video sharing site
Advent Contact: Peter Baines
Dailymotion
Echovox Mobile media solutions provider
Advent Contact: Frédéric Court
Echovox